These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23502989)

  • 21. Preprocedural statin use is associated with a reduced hazard of postprocedural myonecrosis in patients undergoing rotational atherectomy--a propensity-adjusted analysis.
    Gurm HS; Breitbart Y; Vivekanathan D; Yen MH; Fathi R; Ziada KM; Whitlow PL; Ellis SG
    Am Heart J; 2006 May; 151(5):1031.e1-6. PubMed ID: 16644330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin therapy is associated with lower mortality among patients with severe heart failure.
    Mozaffarian D; Nye R; Levy WC
    Am J Cardiol; 2004 May; 93(9):1124-9. PubMed ID: 15110204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin dilemma in the management of chronic heart failure.
    Celik T; Demirkol S
    Int J Cardiol; 2011 Mar; 147(3):452-3. PubMed ID: 21277029
    [No Abstract]   [Full Text] [Related]  

  • 24. Statin Recapture Therapy before Coronary Artery Bypass Grafting Trial: Rationale and study design of a multicenter, randomized, double-blinded controlled clinical trial.
    Liakopoulos OJ; Kuhn EW; Hellmich M; Kuhr K; Krause P; Reuter H; Thurat M; Choi YH; Wahlers T;
    Am Heart J; 2015 Jul; 170(1):46-54, 54.e1-2. PubMed ID: 26093863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.
    Hognestad A; Dickstein K; Myhre E; Snapinn S; Kjekshus J;
    Am J Cardiol; 2004 Mar; 93(5):603-6. PubMed ID: 14996587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Statins Modify the Wound Healing Process After Myocardial Infarction?
    Hasegawa H
    Int Heart J; 2017 Aug; 58(4):472-474. PubMed ID: 28717118
    [No Abstract]   [Full Text] [Related]  

  • 27. Statin therapy in heart failure.
    Soaly E; Al Suwaidi J
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):5-7. PubMed ID: 15723569
    [No Abstract]   [Full Text] [Related]  

  • 28. Statin therapy in congestive heart failure.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Jul; 14(4):338-40. PubMed ID: 15980426
    [No Abstract]   [Full Text] [Related]  

  • 29. Statin use and risks for death and hospitalization in chronic heart failure.
    Suissa S
    JAMA; 2007 Mar; 297(10):1057; author reply 1058. PubMed ID: 17356023
    [No Abstract]   [Full Text] [Related]  

  • 30. Statin use and risks for death and hospitalization in chronic heart failure.
    Gerard W; Gerard J
    JAMA; 2007 Mar; 297(10):1057-8; author reply 1058. PubMed ID: 17356022
    [No Abstract]   [Full Text] [Related]  

  • 31. Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure.
    Xie RQ; Cui W; Liu F; Yang C; Pei WN; Lu JC
    Int J Cardiol; 2010 Apr; 140(2):255-7. PubMed ID: 19042044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.
    Strey CH; Young JM; Molyneux SL; George PM; Florkowski CM; Scott RS; Frampton CM
    Atherosclerosis; 2005 Mar; 179(1):201-6. PubMed ID: 15721028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin therapy for patients with chronic heart failure.
    Gong K; Song G; Zhang Z
    Am J Cardiol; 2006 Sep; 98(5):707. PubMed ID: 16923467
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.
    Feldman AM; Bristow MR; Parmley WW; Carson PE; Pepine CJ; Gilbert EM; Strobeck JE; Hendrix GH; Powers ER; Bain RP
    N Engl J Med; 1993 Jul; 329(3):149-55. PubMed ID: 8515787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in statin prescription rates, adequacy of dosing, and association of statin therapy with outcome after heart failure hospitalization: a retrospective analysis in a community setting.
    Ballo P; Balzi D; Barchielli A; Turco L; Franconi F; Zuppiroli A
    Eur J Clin Pharmacol; 2016 Mar; 72(3):311-9. PubMed ID: 26581760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.
    Kjekshus J; Dunselman P; Blideskog M; Eskilson C; Hjalmarson A; McMurray JV; Waagstein F; Wedel H; Wessman P; Wikstrand J;
    Eur J Heart Fail; 2005 Oct; 7(6):1059-69. PubMed ID: 16227145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathy.
    Kass DA; Van Anden E; Becker LC; Kasper EK; White WB; Feldman AM
    Am J Cardiol; 1996 Sep; 78(6):652-6. PubMed ID: 8831399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and problems of cardiotonic agents viewed from physiopathology of chronic congestive heart failure].
    Asanoi H; Inoue H
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1465-9. PubMed ID: 8537751
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacology update: statin therapy lowers mortality in elders with severe heart failure.
    Luggen AS
    Geriatr Nurs; 2004; 25(4):250. PubMed ID: 15311206
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of statin therapy on the production of monocyte pro-inflammatory cytokines, cardiac function, and long-term prognosis in chronic heart failure patients with dyslipidemia.
    Nakagomi A; Seino Y; Kohashi K; Kosugi M; Endoh Y; Kusama Y; Atarashi H; Mizuno K
    Circ J; 2012; 76(9):2130-8. PubMed ID: 22785006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.